Hearing News Watch

Featured image for “Treble Health’s Annual Tinnitus Relief Summit to Take Place During Tinnitus Awareness Week”
Jan. 30, 2024

Treble Health’s Annual Tinnitus Relief Summit to Take Place During Tinnitus Awareness Week

HHTM
The Tinnitus Relief Summit, a free, annual gathering for individuals with ringing in the ears is set to stream on February 7th and February 8th. Each day will have a unique panel of tinnitus experts, who will share their latest research-based findings and actionable tips for how to reduce tinnitus and thrive. This annual event, taking place during Tinnitus Awareness
Featured image for “Hearing Loss Hits Rural America Hardest, New Study Finds”
Jan. 27, 2024

Hearing Loss Hits Rural America Hardest, New Study Finds

HHTM
In a new study published this week in The Lancet Regional Health – Americas reveals stark geographic divides in hearing loss prevalence across the United States. Researchers at NORC at the University of Chicago estimated hearing loss rates not just nationwide, but also at the state and county levels for the first time. The results show hearing loss impacts rural
Featured image for “First U.S. Gene Therapy Procedure for Genetic Hearing Loss Performed at Children’s Hospital of Philadelphia”
Jan. 25, 2024

First U.S. Gene Therapy Procedure for Genetic Hearing Loss Performed at Children’s Hospital of Philadelphia

HHTM
PHILADELPHIA, PENNSYLVANIA — Children’s Hospital of Philadelphia (CHOP) announced the initial results of an experimental gene therapy treatment for a patient with hereditary hearing loss in the United States. Findings to date indicate the treatment was successful. While the specific gene involved is quite rare, the milestone represents a breakthrough in treating patients around the world with hearing loss caused
Featured image for “Eli Lilly: Gene Therapy Clinical Trial Restores Hearing in First Participant Within 30 Days”
Jan. 24, 2024

Eli Lilly: Gene Therapy Clinical Trial Restores Hearing in First Participant Within 30 Days

HHTM
INDIANAPOLIS, INDIANA — Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), announced positive initial clinical results from the Phase 1/2 AK-OTOF-101 study, which demonstrated restored hearing within 30 days of AK-OTOF administration in the first participant, an individual with over a decade of profound hearing loss. Results, including initial data from a second participant who
Featured image for “Washington Post Article Highlights Promise of Bimodal Neuromodulation’s Role in Addressing Tinnitus”
Jan. 24, 2024

Washington Post Article Highlights Promise of Bimodal Neuromodulation’s Role in Addressing Tinnitus

HHTM
Millions of individuals plagued by tinnitus, a condition causing persistent ringing or other sounds in the ears, may find relief through an innovative treatment that aims to retrain the brain. The Washington Post’s recent article by Amanda Morris and Aaron Steckelberg sheds light on the promising developments in tinnitus treatment, with a focus on bimodal neuromodulation techniques. Tinnitus, affecting approximately
Featured image for “NASEM Holds Second Meeting on Developing Standardized Hearing Healthcare Outcome Measures”
Jan. 23, 2024

NASEM Holds Second Meeting on Developing Standardized Hearing Healthcare Outcome Measures

HHTM
WASHINGTON, D.C. — Earlier this month, the National Academies of Science, Engineering, and Medicine (NASEM) convened an open information-gathering session to launch a new committee focused on improving adult hearing healthcare. With an emphasis on meaningful measures, the committee seeks to define standard outcome measures, identify core outcome domains, and create a framework for developing standardized measures across diverse settings.
Featured image for “Amplifon Acquires Major Miracle-Ear Franchisee, Expanding US Presence of Corporate-Owned Clinics”
Jan. 22, 2024

Amplifon Acquires Major Miracle-Ear Franchisee, Expanding US Presence of Corporate-Owned Clinics

HHTM
MILAN, ITALY — Global hearing care retailer, Amplifon announced Monday it has acquired a large franchisee of the Miracle-Ear brand in the United States. The purchase includes around 50 retail locations across four states. The acquired business is made up of three companies – Hearing Pro Inc, Las Davis Enterprises Inc, and Miracle-Ear Centers of Arkansas LLC. Their combined network
Featured image for “Sensorion Receives Green Light for Phase 1/2 Clinical Trial of Lead Gene Therapy SENS-501 (OTOF-GT) in Europe”
Jan. 19, 2024

Sensorion Receives Green Light for Phase 1/2 Clinical Trial of Lead Gene Therapy SENS-501 (OTOF-GT) in Europe

HHTM
MONTPELLIER, FRANCE — Sensorion, a French clinical-stage biotechnology company focused on novel therapies for hearing loss disorders, today announced a major milestone in bringing its lead gene therapy candidate SENS-501 to human trials. The company received approval to initiate a Phase 1/2 clinical trial evaluating SENS-501 in children with a rare form of genetic deafness in France. The conclusion of
Featured image for “Raising Awareness: Third Annual Nationwide Fundraiser by Texas Roadhouse and Bubba’s 33 for the American Tinnitus Association”
Jan. 18, 2024

Raising Awareness: Third Annual Nationwide Fundraiser by Texas Roadhouse and Bubba’s 33 for the American Tinnitus Association

HHTM
On February 5th, Texas Roadhouse restaurants across the country will host a special fundraising event to support the American Tinnitus Association (ATA) and raise awareness for tinnitus. The event, held on the first day of Tinnitus Awareness Week, invites guests to dine at their local Texas Roadhouse or Bubba’s 33. All profits for the day will be donated to the
Featured image for “HearUSA Announces Plans to Open 17 New ‘Hearing Centers of the Future’ in 2024”
Jan. 18, 2024

HearUSA Announces Plans to Open 17 New ‘Hearing Centers of the Future’ in 2024

HHTM
PALM BEACH GARDENS, FLORIDA — Hearing care retailer HearUSA today accelerated its mission of expanding access to Simply Excellent Hearing Care in 2024 with the announcement of 17 planned Hearing Center of the Future openings in California, Florida, Michigan, and Texas. The new centers are an addition to the eight centers that opened in 2023, all with the goal of bringing